CURIS LIFESCIENCES LTD (CURIS-SM): CURIS LIFESCIENCES Share Price rises 8.65% to Rs 216
- September 7, 2026
- Posted by: Harsh Piplani
- Category: News
CURIS LIFESCIENCES Share Price is in focus today after the stock rose 8.65% to Rs 216, with market capitalisation at Rs 160.72 Cr. The move lifted CURIS LIFESCIENCES LTD into the day’s stock news flow, even as the latest Univest figures do not establish a company-specific catalyst. The stock opened at Rs 211 and touched Rs 218.65, showing a firm share price rise in early trade.
For investors tracking CURIS LIFESCIENCES Share Price Today, the key point is that the price action is real and measurable, but the reason behind it is not confirmed by the available market inputs. In that setting, Univest data makes the event relevant for a closer look at valuation, earnings quality and the company’s place in the Pharmaceuticals & Drugs industry. The move also places CURIS LIFESCIENCES Stock News on the radar for readers following stocks in news across the Indian stock market.
CURIS LIFESCIENCES Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 216 |
| Previous Close | Rs 198.8 |
| Today's Move | Rs 17.2 (+8.65%) |
| Open | Rs 211 |
| High | Rs 218.65 |
| Low | Rs 211 |
| Turnover | Rs 0.39 crore |
| Market Capitalisation | Rs 160.72 crore |
| Market Cap Category | Micro Cap |
CURIS LIFESCIENCES LTD (CURIS-SM) rose to Rs 216 from the previous close of Rs 198.8, a move of Rs 17.2 or 8.65%. The stock opened at Rs 211, reached a high of Rs 218.65, recorded a low of Rs 211.
CURIS LIFESCIENCES Share Price Today moved from a previous close of Rs 198.8 to Rs 216, a gain of Rs 17.2 or 8.65%. The stock traded between Rs 211 and Rs 218.65 during the period covered here, and turnover stood at Rs 0.39 Cr. This confirms a clear intraday price rise, but the latest Univest data does not establish a company-specific reason. For readers scanning CURIS LIFESCIENCES Share Price Live or CURIS LIFESCIENCES Share Price Update, the essential takeaway is simple: the stock was among the notable stocks rising today in healthcare-related market news.
CURIS LIFESCIENCES LTD (CURIS-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 160.72 crore |
| P/E Ratio | 23.24x |
| P/B Ratio | 3.39x |
| ROE | 55.25% |
| ROCE | 34.25% |
| EPS | Rs 8.56 |
| Book Value Per Share | Rs 58.58 |
| Dividend Yield | 0% |
CURIS LIFESCIENCES LTD (CURIS-SM) fundamental metrics show P/E 23.24x, P/B 3.39x, ROE 55.25%, ROCE 34.25%. These figures provide context only and are not a buy or sell signal.
CURIS LIFESCIENCES LTD has a market capitalisation of Rs 160.72 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.24x, P/B at 3.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 55.25% and ROCE of 34.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.56, book value per share of Rs 58.58, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.19x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.24x |
| Benchmark Median P/E | 32.19x |
| Benchmark Average P/E | 49.13x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | 3.39x |
| Benchmark Median P/B | 3.05x |
| Company ROE | 55.25% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 34.25% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 160.72 crore |
| Benchmark Median Market Cap | Rs 715.6 crore |
CURIS LIFESCIENCES LTD (CURIS-SM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
CURIS LIFESCIENCES LTD (CURIS-SM) has a P/E ratio of 23.24x, which is below the benchmark median of 32.19x, a difference of -27.8%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
CURIS LIFESCIENCES LTD (CURIS-SM) has a ROE of 55.25%, which is above the benchmark median of 11.82%, a difference of +367.43%. CURIS LIFESCIENCES LTD (CURIS-SM) has a ROCE of 34.25%, which is above the benchmark median of 13.71%, a difference of +149.82%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,825.66 | 37.31 | 5.22 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,018.51 | 86.86 | 14.38 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,86,874.73 | 86.55 | 21.03 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,211.69 | 25.42 | 4.25 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,773 | 33.17 | 3.18 | 11.83 | 16 |
CURIS LIFESCIENCES LTD (CURIS-SM) has a P/E ratio of 23.24x compared with the displayed peer median of 37.31x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 55.25% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 34.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. CURIS LIFESCIENCES LTD (CURIS-SM) has a market capitalisation of Rs 160.72 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching CURIS LIFESCIENCES
- CURIS LIFESCIENCES Share Price rose 8.65% to Rs 216, putting it on the list of stocks in news today.
- The stock’s P/E of 23.24 is below the industry benchmark median of 32.19, which keeps valuation in focus.
- ROE of 55.25 and ROCE of 34.25 stand out versus the same-industry benchmark set.
- Market capitalisation of Rs 160.72 Cr places the company in a much smaller bracket than many healthcare peers.
- Healthcare sector and pharmaceuticals context may keep CURIS LIFESCIENCES Share Price News active with investors tracking market movers.
About CURIS LIFESCIENCES
CURIS LIFESCIENCES LTD operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following CURIS LIFESCIENCES Company News, the company’s market profile is best understood through its listed financial ratios and sector placement rather than through broad market size. The business is part of a crowded and competitive pharmaceutical universe, where earnings quality, capital efficiency and valuation often matter as much as headline price movement.
Based on the latest Univest figures, CURIS LIFESCIENCES Share Price is being watched not only for its day move, but also for how the company compares on return ratios, book value and earnings per share. That makes CURIS LIFESCIENCES Stock Performance relevant to investors screening the healthcare pack for smaller listed names with visible financial metrics. For anyone tracking CURIS LIFESCIENCES Latest News, the stock’s place in pharmaceuticals gives context to its share price rise today.
Frequently Asked Questions
Why did CURIS LIFESCIENCES share price rise today?
Ans. CURIS LIFESCIENCES Share Price rose 8.65% to Rs 216 in the latest market move. The market data confirms the rise, but it does not establish a company-specific catalyst for the change.
What is CURIS LIFESCIENCES Share Price Today?
Ans. CURIS LIFESCIENCES Share Price Today is Rs 216. It moved up from Rs 198.8 previously, and the stock traded between Rs 211 and Rs 218.65 in the period covered here.
How much did CURIS LIFESCIENCES stock gain today?
Ans. CURIS LIFESCIENCES stock gained Rs 17.2, which is 8.65% over the previous close. That makes it one of the more notable healthcare movers in today’s market update. The previous close was Rs 198.8.
What is the market cap of CURIS LIFESCIENCES?
Ans. CURIS LIFESCIENCES has a market capitalisation of Rs 160.72 Cr. That size places it well below the industry median market cap of Rs 715.6 Cr in the same-industry benchmark set.
Is CURIS LIFESCIENCES expensive or cheap on valuation?
Ans. CURIS LIFESCIENCES Share Price is backed by a P/E of 23.24 and P/B of 3.39. Versus the industry median P/E of 32.19, the earnings multiple looks lower than the benchmark median.
What do CURIS LIFESCIENCES EPS and book value show?
Ans. EPS is Rs 8.56 and book value is Rs 58.58. EPS reflects earnings per share, while book value indicates accounting net worth per share behind the current CURIS LIFESCIENCES Share Price.
How does CURIS LIFESCIENCES compare with healthcare peers?
Ans. CURIS LIFESCIENCES has a smaller market cap than the listed peers in this comparison, but its ROE of 55.25 and ROCE of 34.25 are stronger than the peer figures shown.
Should investors track CURIS LIFESCIENCES on Univest?
Ans. Yes. Univest lets investors track CURIS LIFESCIENCES Share Price, valuation ratios, sector benchmarks and market cap in one place, making it useful for following the stock’s daily movement and financial context.
Track CURIS LIFESCIENCES Share Price on Univest
Use CURIS LIFESCIENCES LTD (CURIS-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track CURIS LIFESCIENCES Share Price on Univest for live price updates, key valuation ratios, financial analysis, sector context and company insights in one place. The Univest stock page also helps readers follow CURIS LIFESCIENCES Share Price Today, CURIS LIFESCIENCES Stock News and broader CURIS LIFESCIENCES Stock Analysis.
For ongoing monitoring, Univest brings together market cap, EPS, book value, dividend yield, peer comparison, industry benchmarks and the latest stock market update. That makes it easier to review CURIS LIFESCIENCES Share Price Rise alongside the company’s fundamentals and healthcare sector positioning.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
